Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting enzymes involved in inflammatory diseases and cancer. Its structure enables selective binding to specific protein targets, making it valuable in developing small-molecule therapeutics. Also employed in the design of compounds with improved metabolic stability and bioavailability. Commonly utilized in structure-activity relationship (SAR) studies to optimize drug candidates.